About lanreotide acetate
Somatostatin analogue
Used for
- Acromegaly when surgery or other treatments are unsuitable or insufficient
- Symptom control in gastroenteropancreatic neuroendocrine tumours
- Treatment of certain unresectable or metastatic gastroenteropancreatic neuroendocrine tumours
Usual adult dose
Acromegaly: usually 90 mg deep under the skin every 4 weeks initially. Tumour-related uses: usually 120 mg every 4 weeks; dose and interval may vary.
Common side effects
- Diarrhoea, abdominal pain, nausea or vomiting
- Gallstones and gallbladder inflammation
- Injection-site pain or lumps
- Slow heartbeat or changes in blood sugar
Important warnings
- Can cause gallstones, slow heart rate, and changes in blood sugar
- May affect thyroid function; monitoring may be needed
- Tell clinicians about other medicines, especially those affecting heart rate or blood sugar
- Given by deep subcutaneous injection by a trained healthcare professional
Pregnancy
Use during pregnancy only when clearly needed; human safety information is limited.
Breastfeeding
Breastfeeding is generally not recommended during treatment; human safety information is limited.
Interactions
- May increase effects of medicines that slow heart rate, such as beta blockers
- Can affect insulin or oral diabetes medicines, requiring monitoring
- May alter absorption of ciclosporin
- May affect medicines metabolised by CYP3A4, such as bromocriptine
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.